Adaptive Molecular Imaging and Therapy Systems for Specialized Environments

Publication ID: 24-11857648_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Molecular Imaging and Therapy Systems for Specialized Environments,” Published Technical Disclosure No. 24-11857648_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857648_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,648.

Summary of the Inventive Concept

The present inventive concept discloses novel molecular imaging and therapy systems tailored for specific, high-demand environments, such as high-security facilities, disaster relief scenarios, extreme weather conditions, and high-temperature settings. These adaptive systems integrate multivalent molecules, detectable labels, and/or drugs with specialized components to ensure effective and secure operation in these unique contexts.

Background and Problem Solved

The original patent disclosed a multivalent molecular imaging and/or targeted drug delivery method, but it did not address the specific challenges and requirements of niche environments. The present inventive concept solves this problem by providing specialized variations of the original concept, adapted for use in high-security, disaster relief, extreme weather, and high-temperature settings.

Detailed Description of the Inventive Concept

The inventive concept encompasses four primary embodiments: (1) a system for high-security molecular imaging and/or radioimmunotherapy, featuring secure authentication mechanisms; (2) a method for targeted molecular imaging and/or therapy in disaster relief scenarios, utilizing portable, ruggedized devices; (3) a kit for molecular imaging and/or therapy in extreme weather conditions, incorporating weather-resistant packaging systems; and (4) a system for molecular imaging and/or radioimmunotherapy in high-temperature environments, employing heat-resistant formulations. Each embodiment leverages the original patent's multivalent molecule technology, while incorporating specialized components to address the unique demands of its target environment.

Novelty and Inventive Step

The present inventive concept's novelty lies in its adaptation of the original patent's multivalent molecule technology for specific, high-demand environments. The inventive step resides in the integration of specialized components, such as secure authentication mechanisms, ruggedized devices, weather-resistant packaging systems, and heat-resistant formulations, which enable effective and secure operation in these unique contexts.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include systems for molecular imaging and/or therapy in other specialized environments, such as low-temperature settings, high-radiation areas, or space exploration. Additionally, variations of the inventive concept could incorporate different types of detectable labels, drugs, or multivalent molecule structures to further expand its applicability.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in various industries, including healthcare, biotechnology, and pharmaceuticals. Target markets may include high-security facilities, disaster relief organizations, and companies operating in extreme environments. The adaptive molecular imaging and therapy systems disclosed herein could provide a competitive advantage in these niches, enabling more effective and secure operations.

CPC Classifications

SectionClassGroup
A A61 A61K51/082
A A61 A61K9/51
A A61 A61K47/6893
A A61 A61K51/1027
C C07 C07D255/02
C C07 C07D257/02
C C07 C07K7/06
C C07 C07K7/64
C C07 C07K16/30
G G01 G01N33/5008
G G01 G01N33/60
C C07 C07K2319/00

Field of Art

Molecular imaging, radioimmunotherapy, and targeted drug delivery systems, involving complex chemical synthesis of multivalent molecules with specific peptide sequences, chelators, and detectable labels. Requires advanced knowledge in organic chemistry, biochemistry, radiochemistry, and bioconjugate engineering

Person of Ordinary Skill (PHOSITA) Profile

A PhD-level researcher with expertise in radiochemistry, molecular biology, and biomedical engineering, familiar with peptide conjugation techniques, radioisotope labeling, and multivalent molecular design strategies

Obviousness Rationale

A PHOSITA would recognize that adapting the source patent's multivalent molecular imaging technology to specialized environments represents a straightforward engineering optimization. The core molecular design remains consistent, with modifications focused on environmental adaptability being well within routine experimental capabilities. The variations represent predictable extensions of the original molecular imaging framework using standard biomedical engineering techniques.

Obvious Combinations & Variations

Source Patent Element
Multivalent molecule with peptide targeting and chelator for molecular imaging
PTD Variation
Integrating secure authentication mechanisms with the molecular imaging system
Obviousness Reasoning
Adding authentication to a molecular imaging system is a predictable security enhancement using known access control technologies, representing a standard design choice for sensitive medical technologies
Source Patent Element
Detectable labels including radioisotopes and fluorescent dyes
PTD Variation
Developing weather-resistant packaging systems for molecular imaging compounds
Obviousness Reasoning
Protecting sensitive molecular compounds through specialized packaging is a routine engineering solution for maintaining stability in challenging environmental conditions
Source Patent Element
Peptide-based multivalent molecules with chelators and labels
PTD Variation
Creating heat-resistant formulations for high-temperature molecular imaging systems
Obviousness Reasoning
Modifying molecular compound stability for extreme temperatures is a standard materials engineering approach using known chemical stabilization techniques
Source Patent Element
Molecular imaging compounds with multiple biomarker targeting capabilities
PTD Variation
Developing portable, ruggedized devices for disaster relief molecular imaging
Obviousness Reasoning
Adapting medical technologies for field deployment represents a predictable engineering optimization using standard ruggedization techniques
Source Patent Element
Chelator and peptide conjugation strategies
PTD Variation
Implementing tamper-evident containers for high-security molecular imaging compounds
Obviousness Reasoning
Adding security packaging to sensitive medical compounds is a routine design modification using established containment technologies
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed herein would have been obvious to a person of ordinary skill in the art at the time of invention, as they represent predictable extensions of the molecular imaging technology disclosed in US Patent 11857648, utilizing standard engineering modifications to adapt the core molecular design to specialized environmental contexts.

Original Patent Information

Patent NumberUS 11,857,648
TitleDimerization strategies and compounds for molecular imaging and/or radioimmunotherapy
Assignee(s)UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION